Today: 20 May 2026
Browse Category

NASDAQ:NUVB 20 November 2025 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio shares fell 4.7% to $8.05 Friday afternoon, underperforming biotech peers. UBS began coverage at Neutral with a $10 target, while RBC raised its target to $9 and reiterated Outperform. CEO David Hung is set to present at the J.P. Morgan Healthcare Conference on Jan. 13. Investors await early March results for updates on IBTROZI’s launch and pipeline spending.
9 January 2026
·
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio shares surged 49% to $7.15 on November 20, 2025, hitting a three-year high after Q3 revenue of $13.1 million nearly doubled analyst estimates. Uptake of its lung-cancer drug IBTROZI drove $7.7 million in U.S. sales and 204 new patient starts. Multiple analysts raised price targets, with the average now at $10.13. Trading volume spiked, extending a multi-day rally.
20 November 2025
·

Stock Market Today

  • Oil Prices Fall After Trump Comments on Ending Iran War
    May 20, 2026, 7:14 AM EDT. Oil prices declined on Tuesday following President Trump's statement reaffirming his intent to end the conflict with Iran "very quickly." The Strait of Hormuz, a critical chokepoint for global oil shipments, experienced one of its busiest days since its recent closure, underscoring the region's importance to energy markets and the potential impact of geopolitical developments on supply dynamics.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Go toTop